COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 594: Articles 5931-5940  | Next

Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia?
Furuzawa-Carballeda, J., Icaza-Chavez, M. E., Aguilar-Leon, D., Uribe-Uribe, N., Nunez-Pompa, M. C., Trigos-Diaz, A., Arean-Sanz, R., Fernandez-Camargo, D. A., Coss-Adame, E., Valdovinos, M. A., Briceno-Souza, E., Chi-Cervera, L. A., Olivares-Flores, M., Torres-Villalobos, G.
10.1101/2022.09.19.22280068 — Posted: 2022-09-20
The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants
Thompson, R. N., Southall, E., Daon, Y., Lovell-Read, F. A., Iwami, S., Thompson, C. P., Obolski, U.
10.1101/2022.09.20.22280161 — Posted: 2022-09-20
Age-Associated B cells predict impaired humoral immunity after COVID-19 vaccination in patients receiving immune checkpoint blockade
Yam-Puc, J. C., Hosseini, Z., Horner, E. C., Gerber, P. P., Beristain-Covarrubias, N., Hughes, R., Rust, M., Boston, R., Ali, M., Simmons Rosello, E., O'Reilly, M., Robson, H., Booth, L. H., Kahanawita, L., Grigoriadou, S., Correa-Noguera, A., Ceron-Guiterez, L., Mulroney, T., Lulla, A., Fischer, K., Craxton, A., Anderson, G. S., Sun, X.-M., Elmer, A., Saunders, C., Bermperi, A., Jose, S., Chapman, M., MacFarlane, M., Willis, A. E., Patil, K. R., Hollfelder, F., Hyvonen, M., CITIID-NIHR COVID-19 BioResource Collaboration, , Spencer, S., Staples, E., Buckland, M. S., Doffinger, R., Parkinson, C., Lear, S., Matheson, N. J., Thaventhiran, J. E.
10.1101/2022.09.17.22280033 — Posted: 2022-09-20
Therapeutic and Interventional Bronchoscopy Performed in Critically ill COVID-19 patients: A Systematic Review
Samadder, S.
10.1101/2022.09.19.22280133 — Posted: 2022-09-20
The impact of prior COVID-19 on vaccine response and the resultant hybrid immunity are age-dependent
Nakagama, S., Nakagama, Y., Komase, Y., Kudo, M., Imai, T., Nitahara, Y., Kaku, N., Tshibangu-Kabamba, E., Kido, Y.
10.1101/2022.09.19.22280079 — Posted: 2022-09-19
Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19
Schultheiss, C., Willscher, E., Paschold, L., Gottschick, C., Klee, B., Bosurgi, L., Dutzmann, J., Sedding, D., Frese, T., Girndt, M., Hoell, J. I., Gekle, M., Mikolajczyk, R., Binder, M.
10.1101/2022.09.18.22280022 — Posted: 2022-09-19
Comparison of a prototype SARS-CoV-2 lateral flow immunoassay with the BinaxNOW™ COVID-19 Antigen CARD
Hill, H. J., Uppal, T., Hau, D., Pandit, S. G., Arias-Umana, J., Foster, A. J., Gorzalski, A., Pflughoeft, K. J., Burnham-Marusich, A. R., Reed, D. E., Gates-Hollingsworth, M. A., Gumbleton, L., Verma, S. C., AuCoin, D. P.
10.1101/2022.09.16.22279736 — Posted: 2022-09-19
Lung remodeling regions in long-term Covid-19 feature basal epithelial cell reprogramming
Wu, K., Zhang, Y., Austin, S. R., Yin Declue, H., Byers, D. E., Crouch, E. C., Holtzman, M. J.
10.1101/2022.09.17.22280043 — Posted: 2022-09-19
Wastewater based epidemiology beyond SARS-CoV-2: Spanish wastewater reveals the current spread of Monkeypox virus
Giron Guzman, I., Diaz-Reolid, A., Truchado, P., Carcereny, A., Garcia-Pedemonte, D., Hernaez, B., Bosch, A., Pinto, R. M., Guix, S., Allende, A., Alcami, A., Perez-Cataluna, A., Sanchez, G.
10.1101/2022.09.19.22280084 — Posted: 2022-09-19
Antibody avidity maturation favors SARS-CoV-2 convalescents over vaccinated individuals granting breadth in neutralizability and tolerance against variants
Nakagama, Y., Candray, K., Kaku, N., Komase, Y., Rodriguez-Funes, M.-V., Dominguez, R., Tsuchida, T., Kunishima, H., Nagai, E., Adachi, E., Ngoyi, D. M., Yamasue, M., Komiya, K., Hiramatsu, K., Uemura, N., Sugiura, Y., Yasugi, M., Yamagishi, Y., Mikamo, H., Shiraishi, S., Izumo, T., Nakagama, S., Watanabe, C., Nitahara, Y., Tshibangu-Kabamba, E., Kakeya, H., Kido, Y.
10.1101/2022.09.19.22280078 — Posted: 2022-09-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).